A study on how the newest modulator medication elexacaftor/tezacaftor/ivacaftor affects the gut over time using MRI scans
Lung function and imaging outcomes in children with cystic fibrosis diagnosed after newborn screening
Elexacaftor/Tezacaftor/Ivacaftor Improves Chronic Rhinosinusitis Detected by Magnetic Resonance Imaging in Children with Cystic Fibrosis on Long-Term Therapy with Lumacaftor/Ivacaftor
Magnetic resonance imaging of the gastrointestinal tract shows reduced small bowel motility and altered chyme in cystic fibrosis compared to controls
A two-center analysis of hyperpolarized 129Xe lung MRI in stable pediatric cystic fibrosis: Potential as a biomarker for multi-site trials.
Comparison of Lung Clearance Index Determined by Washout of N2 and SF6 in Infants and Preschool Children with Cystic Fibrosis
Multicentre Standardisation of Chest MRI as Radiation-Free Outcome Measure of Lung Disease in Young Children with Cystic Fibrosis
Preliminary Comparison of Normalized T1 and Non-Contrast Perfusion MRI Assessments of Regional Lung Disease in People with Cystic Fibrosis
